|1.||Studneva, Irina M: 1 article (03/2015)|
|2.||Pisarenko, Oleg I: 1 article (03/2015)|
|3.||Pelogeykina, Yulia A: 1 article (03/2015)|
|4.||Shulzhenko, Valentin S: 1 article (03/2015)|
|5.||Man, Yu-Bun: 1 article (02/2011)|
|6.||He, Guo-Wei: 1 article (02/2011)|
|7.||Yang, Qin: 1 article (02/2011)|
|8.||Yao, Xiao-Qiang: 1 article (02/2011)|
|9.||Huang, Jun-Hao: 1 article (02/2011)|
|10.||Seymen, Hakki Oktay: 1 article (06/2008)|
04/01/1988 - "This study was designed to determine whether multidose St. Thomas' Hospital cardioplegic solution is as effective for preservation of the immature myocardium during ischemia as it is for the mature myocardium. "
06/01/1990 - "In further studies, groups of 6 hearts were infused for 2 minutes with St. Thomas' Hospital Cardioplegic Solution, then subjected to 30 minutes of ischemia. "
03/01/1990 - "The objective of the present study was to compare the vulnerability of the two preparations to global ischemia and their responsiveness to protection with the St Thomas' Hospital cardioplegic solution. "
03/01/2015 - "St. Thomas' Hospital cardioplegic solution No.2 (STH2) containing 140 μM A12, AI, or AII was infused for 5 min at 25 °C before ischemia. "
04/01/2001 - "After 15 minutes of stable function, each heart sustained 180 minutes of cold (4 degrees C) ischemia after a 5-minute perfusion by University of Missouri (UMC), Plegisol, Collins, University of Wisconsin, Custodiol, or Roe solutions. "
|2.||Heart Arrest (Cardiac Arrest)
10/01/1993 - "Protective effects of oxygenated St. Thomas' Hospital cardioplegic solution during ischaemic cardiac arrest: improved function, metabolism and ultrastructure."
10/01/1989 - "Cardiac arrest was with St. Thomas' hospital cardioplegic solution in all patients. "
04/01/1989 - "The isolated perfused working rat heart model of cardiopulmonary bypass and ischaemic cardiac arrest has been used to investigate whether addition of various organic anti-oxidants to the St Thomas' Hospital cardioplegic solution can enhance the recovery of function of the rat myocardium after normothermic (37 degrees C) global ischaemic arrest. "
06/01/2007 - "Cardiac arrest was achieved using St. Thomas' Hospital cardioplegic solution for 3 min. Each heart was subjected to global ischemia at 37 degrees C for 45 min followed by reperfusion for 60 min. In protocol A, landiolol (5-200 microM) was administered before ischemia and in protocol B, landiolol (10-1000 microM) was administered during ischemia. "
03/01/1993 - "Proton gradient during cardiac arrest: oxygenation of St. Thomas' Hospital cardioplegic solution and carbon dioxide level."
02/01/1998 - "Human albumin enriched St. Thomas Hospital cardioplegic solution increases reperfusion injury in isolated perfused rat hearts."
09/01/2005 - "We investigated the advantages of CAPE supplemented cardioplegic solution (St. Thomas' Hospital cardioplegic solution No.: 2) on the antioxidant defense system of myocardium against ischemia-reperfusion injury. "
09/01/2005 - "Caffeic acid phenethyl ester (CAPE) supplemented St. Thomas' hospital cardioplegic solution improves the antioxidant defense system of rat myocardium during ischemia-reperfusion injury."
01/01/1999 - "No beneficial effects of isocolloidoosmotic synthetic colloid addition to St. Thomas Hospital cardioplegic solution in ischemia-reperfusion injury in isolated perfused rat hearts."
01/01/1999 - "We studied the effects of colloidal volume replacers such as dextran, HES and gelatin as an isocolloidoosmotic addition to St. Thomas Hospital cardioplegic solution in ischemia-reperfusion injury of isolated rat hearts. "
09/01/1990 - "In additional studies, hearts were subjected to a 2-min preischemic infusion with the St. Thomas' Hospital cardioplegic solution before either 25 or 35 min of normothermic ischemia and reperfusion with transient hypothermia at 5, 10, 20, or 30 degrees C. "
07/01/2003 - "Myocardial protection consisted of administration of the St.Thomas' Hospital cardioplegic solution, topical slushed ice and systemic hypothermia (28 degrees C-30 degrees C). "
05/01/1993 - "Myocardial protection consisted of St. Thomas' Hospital cardioplegic solution, topical slushed ice, and systemic hypothermia (28 degrees C). "
02/01/2011 - "Hypoxia-reoxygenation (60-30 minutes) decreased endothelium-dependent hyperpolarizing factor-mediated relaxation at normothermia in Krebs solution (43.3%±6.3% vs 82.3%±2.9%) and in St Thomas' Hospital cardioplegic solution (28.9%±1.8% vs 78.1%±3.0%) (P<.001) as well as at hypothermia in St Thomas' Hospital solution (43.1%±2.6%, P<.001). "
02/01/1996 - "We used the blood-perfused rat heart to study the effect of St. Thomas' Hospital cardioplegic solution on postischemic endothelium-dependent and endothelium-independent vascular function, the extent of the no-reflow phenomenon, and the temporal relationship between postischemic vascular and contractile function. "
|6.||Blood Group Antigens (Blood Groups)
|7.||tranilast (N 5')
|1.||Induced Heart Arrest (Cardioplegia)
|2.||Cardiopulmonary Bypass (Heart-Lung Bypass)